In summary, we showed that, in a mouse model of NASH/NAFL, RSV administration can improve inflammation and fibrosis, but not steatosis, via inhibition of LPS reactivity that is due to CD14 expression in Kupffer cells. Here, CD14 is linked to non-alcoholic fatty liver.